Polyclonal Rabbit anti‑Rat GALC / Galactocerebrosidase Antibody (Cy3, aa38‑156, WB) LS‑C704668
Polyclonal Rabbit anti‑Rat GALC / Galactocerebrosidase Antibody (Cy3, aa38‑156, WB) LS‑C704668
Antibody:
GALC / Galactocerebrosidase Rabbit anti-Rat Polyclonal (aa38-156) (Cy3) Antibody
Overview
Antibody:
GALC / Galactocerebrosidase Rabbit anti-Rat Polyclonal (aa38-156) (Cy3) Antibody
Specifications
Description
Galactocerebrosidase antibody LS-C704668 is a Cy3-conjugated rabbit polyclonal antibody to rat Galactocerebrosidase (GALC) (aa38-156). Validated for WB.
Target
Rat GALC / Galactocerebrosidase
Synonyms
GALC | Galactocerebrosidase | GALCERase | Galactosylceramidase | Galactosylceraminidase
Reactivity
Rat
(tested or 100% immunogen sequence identity)
Conjugations
Cy3.
Also available
Unconjugated or conjugated with
Biotin,
FITC,
HRP,
APC,
PE,
APC, Cy7.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Immunogen
Recombinant GALC (Glu38-Ala156) expressed in E. coli.
Specificity
The antibody is a rabbit polyclonal antibody raised against GALC.
Applications
- Western blot
- Applications tested for the base form of this product only
Presentation
PBS, pH 7.4, 0.02% Sodium Azide, 50% Glycerol
Storage
Avoid repeated freeze/thaw cycles. Store at 4°C for frequent use. Aliquot and store at -20°C for 12 months.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About GALC / Galactocerebrosidase
Featured Products
Species:
Human
Applications:
Western blot, ELISA
Species:
Human, Mouse, Rat
Applications:
IHC, Western blot
Species:
Human
Applications:
Western blot
Species:
Human
Applications:
IHC - Paraffin, Western blot
Species:
Human
Applications:
IHC, Western blot, ELISA
Species:
Human
Applications:
IHC, Western blot, ELISA
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 8/31/2024